{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:05:58Z","timestamp":1791461158735,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012502","name":"Suzhou University of Science and Technology Collaborative Innovation Center for Water Treatment Technology and Materials of Jiangsu Province","doi-asserted-by":"publisher","award":["SZM2024012"],"award-info":[{"award-number":["SZM2024012"]}],"id":[{"id":"10.13039\/501100012502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270162"],"award-info":[{"award-number":["32270162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["GZK1202403"],"award-info":[{"award-number":["GZK1202403"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019643","name":"State Key Laboratory of Radiation Medicine and Protection","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20231313"],"award-info":[{"award-number":["BK20231313"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:12:47Z","timestamp":1770397967000},"page":"3023-3038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["LpqH-tagged microvesicles as mRNA vaccine carriers for specific delivery of mRNA into macrophages"],"prefix":"10.1016","volume":"34","author":[{"given":"Fangfang","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1166-8301","authenticated-orcid":false,"given":"Yuxuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.002_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.02.002_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.02.002_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2115463","article-title":"Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans","volume":"386","author":"Dickerman","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.002_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm2311","article-title":"mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions","volume":"14","author":"Kaplonek","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115175","article-title":"The immunostimulatory nature of mRNA lipid nanoparticles","volume":"205","author":"Sharma","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.02.002_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311276120","article-title":"Biomimetic noncationic lipid nanoparticles for mRNA delivery","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.002_bib7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","article-title":"Acid-degradable lipid nanoparticles enhance the delivery of mRNA","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.02.002_bib9","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ymthe.2024.02.025","article-title":"Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles","volume":"32","author":"Muskan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.002_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41551-022-00989-w","article-title":"Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy","volume":"7","author":"You","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.02.002_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib12","doi-asserted-by":"crossref","first-page":"E1433","DOI":"10.1073\/pnas.1418401112","article-title":"Differential fates of biomolecules delivered to target cells via extracellular vesicles","volume":"112","author":"Kanada","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.002_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.384","article-title":"Differential traits between microvesicles and exosomes in enterovirus infection","volume":"4","author":"Fu","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ymthe.2026.02.002_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","article-title":"Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading","volume":"31","author":"R\u00e4dler","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.002_bib16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","article-title":"Extracellular vesicles: The next generation in gene therapy delivery","volume":"31","author":"Cecchin","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.002_bib17","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.02.002_bib18","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.2147\/IJN.S444582","article-title":"Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications","volume":"18","author":"Tian","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2026.02.002_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2024.2333123","article-title":"mRNA vaccine designs for optimal adjuvanticity and delivery","volume":"21","author":"Mochida","year":"2024","journal-title":"RNA Biol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ymthe.2024.01.020","article-title":"Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines","volume":"32","author":"Kubara","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.002_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jconrel.2024.08.018","article-title":"Stealth mRNA nanovaccines to control lymph node trafficking","volume":"374","author":"Garc\u00eda-Fern\u00e1ndez","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.02.002_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.002_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202401712","article-title":"Cholesterol-Derived Mannosylated Polypeptide-Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery","volume":"9","author":"Zeng","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.ymthe.2026.02.002_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100368","article-title":"Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206","volume":"296","author":"Feinberg","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.02.002_bib26","doi-asserted-by":"crossref","first-page":"23134","DOI":"10.1021\/jacs.2c10757","article-title":"Sulfation at Glycopolymer Side Chains Switches Activity at the Macrophage Mannose Receptor (CD206) In Vitro and In Vivo","volume":"144","author":"Mastrotto","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2026.02.002_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.002_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41541-023-00710-1","article-title":"An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis","volume":"8","author":"Krishnananthasivam","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.02.002_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijbiomac.2022.04.196","article-title":"High-resolution crystal structure of LpqH, an immunomodulatory surface lipoprotein of Mycobacterium tuberculosis reveals a distinct fold and a conserved cleft on its surface","volume":"210","author":"Chatterjee","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.02.002_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/cbdd.12365","article-title":"Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro","volume":"84","author":"Ocampo","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ymthe.2026.02.002_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micpath.2005.06.002","article-title":"The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria","volume":"39","author":"Diaz-Silvestre","year":"2005","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ymthe.2026.02.002_bib33","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1128\/JVI.72.7.6159-6163.1998","article-title":"Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein","volume":"72","author":"Abe","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib34","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/mt.2011.138","article-title":"Protein transfer into human cells by VSV-G-induced nanovesicles","volume":"19","author":"Mangeot","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.002_bib35","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v5.31027","article-title":"A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery","volume":"5","author":"Hung","year":"2016","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2026.02.002_bib36","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2022.100002","article-title":"Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung","volume":"1","author":"Popowski","year":"2022","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.ymthe.2026.02.002_bib38","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS nano"},{"key":"10.1016\/j.ymthe.2026.02.002_bib39","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ymthe.2026.02.002_bib40","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.7150\/thno.110305","article-title":"Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes","volume":"15","author":"Wei","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.02.002_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41551-025-01343-6","article-title":"Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection","volume":"9","author":"Wang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.02.002_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ymthe.2017.11.009","article-title":"mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.002_bib43","article-title":"mRNA Delivery System for Targeting Antigen-Presenting Cells In Vivo","volume":"7","author":"Fornaguera","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2026.02.002_bib44","doi-asserted-by":"crossref","first-page":"19550","DOI":"10.1021\/acsnano.3c05635","article-title":"mRNA Cancer Vaccines: Construction and Boosting Strategies","volume":"17","author":"Liu","year":"2023","journal-title":"ACS nano"},{"key":"10.1016\/j.ymthe.2026.02.002_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2022.09.038","article-title":"Mannose in vaccine delivery","volume":"351","author":"Nahar","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.02.002_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1039\/C9BM01766F","article-title":"Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma","volume":"8","author":"Molinaro","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ymthe.2026.02.002_bib47","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/s41598-021-84492-3","article-title":"Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer","volume":"11","author":"De Vita","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.02.002_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","article-title":"Therapeutically harnessing extracellular vesicles","volume":"21","author":"Cheng","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.02.002_bib49","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New Technologies for Analysis of Extracellular Vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ymthe.2026.02.002_bib50","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.matt.2022.06.012","article-title":"Inhalable dry powder mRNA vaccines based on extracellular vesicles","volume":"5","author":"Popowski","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.ymthe.2026.02.002_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jconrel.2024.08.017","article-title":"Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity","volume":"374","author":"Luo","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.02.002_bib52","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.apsb.2022.11.026","article-title":"Lipid carriers for mRNA delivery","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymthe.2026.02.002_bib53","doi-asserted-by":"crossref","first-page":"17309","DOI":"10.1021\/acsnano.4c14573","article-title":"Glioblastoma Cell Derived Exosomes as a Potent Vaccine Platform Targeting Primary Brain Cancers and Brain Metastases","volume":"19","author":"Zou","year":"2025","journal-title":"ACS nano"},{"key":"10.1016\/j.ymthe.2026.02.002_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301010","article-title":"Clinical Translation of Extracellular Vesicles","volume":"12","author":"Ghodasara","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2026.02.002_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molmed.2018.01.006","article-title":"Manufacturing Exosomes: A Promising Therapeutic Platform","volume":"24","author":"Colao","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.02.002_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113673","article-title":"A comprehensive evaluation of stability and safety for HEK293F-derived extracellular vesicles as promising drug delivery vehicles","volume":"382","author":"Chen","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.02.002_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2026.02.002_bib58","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41596-023-00811-0","article-title":"Comprehensive isolation of extracellular vesicles and nanoparticles","volume":"18","author":"Zhang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.02.002_bib59","article-title":"Recent developments in isolating methods for exosomes","volume":"10","author":"Gao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of Exosome Composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.02.002_bib61","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202408159","article-title":"Calpains orchestrate secretion of annexin-containing microvesicles during membrane repair","volume":"224","author":"Williams","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.02.002_bib62","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1016\/j.vaccine.2021.06.011","article-title":"Interpreting vaccine efficacy trial results for infection and transmission","volume":"39","author":"Lipsitch","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.002_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","article-title":"Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques","volume":"626","author":"McMahan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.02.002_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12060670","article-title":"mRNA Technology and Mucosal Immunization","volume":"12","author":"Toniolo","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.02.002_bib65","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41551-022-00902-5","article-title":"Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.02.002_bib66","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41591-018-0161-0","article-title":"Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV","volume":"24","author":"Ackerman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.002_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105875","article-title":"Enterovirus 71-induced autophagosome fusion with multivesicular bodies facilitates viral RNA packaging into exosomes","volume":"173","author":"Zhang","year":"2022","journal-title":"Microb. Pathog."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:36:14Z","timestamp":1781829374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626000894"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.002","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LpqH-tagged microvesicles as mRNA vaccine carriers for specific delivery of mRNA into macrophages","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}